163. Impact of Timely Public Health Measures on Kidney Transplantation in Austria during the SARS-CoV-2 Outbreak-A Nationwide Analysis. J Clin Med. 2020, 9(11):E3465

Watschinger B, Watschinger C, Reindl-Schwaighofer R, Meyer EL, Deak AT, Hammer T, Eigner M, Sprenger-Mähr H, Schneeberger S, Cejka D, Mayer G, Oberbauer R, Rosenkranz AR, Kerschbaum J

162. Cardiac magnetic resonance-derived fibrosis, strain and molecular biomarkers of fibrosis in hypertensive heart disease. J Hypertens. 2020;38(10):2036-2042 (IF )

Pichler G, Redon J, Martínez F, Solaz E, Calaforra O, Andrés MS, Lopez B, Díez J, Oberbauer R, Adlbrecht C, Karth GD, Maceira A.

160. High-activity Classical and Alternative Complement Pathway Genotypes—Association With Donor-specific Antibody-triggered Injury and Renal Allograft Survival. Transplantation Direct 2020, 6 (3):e534

Mező B, Reindl-Schwaighofer R, Eskandary F, Heinzel A, Wahrmann M, Doberer K, Heilos A, Bond G, Kläger J, Kozakowski N, Haslacher H, Oberbauer R, Viklický O, Hrubá P, Halloran PF, Rusai K, Prohászka Z, Böhmig GA

159. Renoprotective and Immunomodulatory Effects of GDF15 following AKI Invoked by Ischemia-Reperfusion Injury. J Am Soc Nephrol. 2020, 31(4):701-715 (IF 10.3)

Liu J, Kumar S, Heinzel A, Gao M, Guo J, Alvarado GF, Reindl-Schwaighofer R, Krautzberger AM, Cippà PE, McMahon J, Oberbauer R, McMahon AP

158. Predicting donor, recipient and graft survival inliving donor kidney transplantation to inform pretransplant counselling: the donor and recipient linked iPREDICTLIVING tool – a retrospective study. Transplant Int 2020, 33(7):729-739 (IF 2.7)

Haller MC, Wallisch C, Mjøen G, Holdaas H, Dunkler D, Heinze G, Oberbauer R

SCIENTIFIC COLLABORATIONS